stockrowAlvotech (ALVO) vs Cronos Group Inc. (CRON)
- Alvotech ALVO 4.58 −1.93%
- Cronos Group Inc. CRON 3.72 +5.98%
Alvotech and Cronos Group Inc. are both Drug Manufacturers Specialty & Generic companies. Alvotech is the larger, with a market value of $1.8B against $1.4B — 1.3× the size. Alvotech has negative trailing earnings, so its P/E is not meaningful; Cronos Group Inc. trades at 21.9×. Alvotech grew revenue faster over the last twelve months: 364.3% against 55.8%. Cronos Group Inc. has the higher net margin (28.0% vs −101.1%) and the higher return on invested capital (1.28% vs 0.00%). Across the 16 metrics below, Cronos Group Inc. leads on 11 and Alvotech on 5.
Valuation
Profitability
| Metric | ALVO | CRON | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 42.71% | 46.59% | 53.51% |
| Operating margin | (42.43%) | 3.78% | 0.00% |
| Net margin | (101.05%) | 28.04% | (2.45%) |
| Free cash flow margin | 0.00% | 31.71% | 0.00% |
| Return on equity | 0.00% | 5.12% | (0.80%) |
| Return on assets | 0.00% | 4.87% | (1.67%) |
| Return on invested capital | 0.00% | 1.28% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack